.jpg?20260812')
The British medicines regulator on Monday authorised Eli Lilly's pill Foundayo for weight management and type 2 diabetes, becoming Europe's first country to do so.
Lilly's GLP-1 tablet, a once-daily drug that targets the GLP-1 hormone, has been gaining momentumin the US since its approval and launchin April, but it still lags rival Novo Nordisk's Wegovy pill.
"Whilst this tablet is approved for use in the UK, it is not available currently via the NHS," the Medicines and Healthcare products Regulatory Agency, or MHRA, said.
&uuid=(email))